{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:43:34Z","timestamp":1787013814076,"version":"build-2736575974"},"reference-count":16,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2018,1,23]],"date-time":"2018-01-23T00:00:00Z","timestamp":1516665600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["obgyn.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Aust NZ J Obst Gynaeco"],"published-print":{"date-parts":[[2018,10]]},"abstract":"<jats:sec>\n                    <jats:title>Background and aims<\/jats:title>\n                    <jats:p>\n                      The aim of this study was to investigate the effectiveness of a levonorgestrel\u2010releasing intrauterine device (\n                      <jats:styled-content style=\"fixed-case\">LNG<\/jats:styled-content>\n                      \u2010\n                      <jats:styled-content style=\"fixed-case\">IUS<\/jats:styled-content>\n                      ) in the symptomatic relief of pain in women with endometriosis and additionally, to assess the changes in women's life quality and serum cancer antigen (\n                      <jats:styled-content style=\"fixed-case\">CA)<\/jats:styled-content>\n                      125 levels.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>\n                      All women who had an\n                      <jats:styled-content style=\"fixed-case\">LNG<\/jats:styled-content>\n                      \u2010\n                      <jats:styled-content style=\"fixed-case\">IUS<\/jats:styled-content>\n                      inserted for the treatment of dysmenorrhea, chronic pelvic pain or both for more than six months over a two\u2010year period were included in the study. Each woman was asked to complete questionnaires of the Short Form\u201036 and visual analogue scales (\n                      <jats:styled-content style=\"fixed-case\">VAS<\/jats:styled-content>\n                      ) in the first visit and the third, sixth, ninth and twelfth months after the\n                      <jats:styled-content style=\"fixed-case\">LNG<\/jats:styled-content>\n                      \u2010\n                      <jats:styled-content style=\"fixed-case\">IUS<\/jats:styled-content>\n                      insertion.\n                      <jats:styled-content style=\"fixed-case\">CA<\/jats:styled-content>\n                      125 levels were measured at each visit.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Forty\u2010five women were included in the study. At the end of 12\u00a0months, mean dysmenorrhoea\n                      <jats:styled-content style=\"fixed-case\">VAS<\/jats:styled-content>\n                      score decreased from 6.13 to 2.88, mean dsyspareunia\n                      <jats:styled-content style=\"fixed-case\">VAS<\/jats:styled-content>\n                      score from 6.04 to 2.61 and\n                      <jats:styled-content style=\"fixed-case\">CA<\/jats:styled-content>\n                      125 level from 50.67 to 22.45. Endometriomas reduced in size in six women (mean size decreased from 31 to 20\u00a0mm) and disappeared in three.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Several favourable outcomes were found following\n                      <jats:styled-content style=\"fixed-case\">LNG<\/jats:styled-content>\n                      \u2010\n                      <jats:styled-content style=\"fixed-case\">IUS<\/jats:styled-content>\n                      insertion: (i) dyspareunia and dysmenorrhoea were clearly reduced; (ii) the size of endometriomas were decreased; (iii)\n                      <jats:styled-content style=\"fixed-case\">CA<\/jats:styled-content>\n                      125 levels significantly decreased; (iv) a few women experienced the typical systemic adverse effects of progestogens; however,\n                      <jats:styled-content style=\"fixed-case\">LNG<\/jats:styled-content>\n                      \u2010\n                      <jats:styled-content style=\"fixed-case\">IUS<\/jats:styled-content>\n                      \u2010related adverse events were generally tolerable and the discontinuation rate was as low as 6.66% (3\/45).\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/ajo.12773","type":"journal-article","created":{"date-parts":[[2018,1,23]],"date-time":"2018-01-23T03:22:41Z","timestamp":1516677761000},"page":"560-563","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["The levonorgestrel\u2010releasing intrauterine system is associated with a reduction in dysmenorrhoea and dyspareunia, a decrease in\n                    <scp>CA<\/scp>\n                    125 levels, and an increase in quality of life in women with suspected endometriosis"],"prefix":"10.1111","volume":"58","author":[{"given":"Nese","family":"Yucel","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynaecology Goztepe Training and Research Hospital Istanbul Medeniyet University  Istanbul Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erdem","family":"Baskent","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology Goztepe Training and Research Hospital Istanbul Medeniyet University  Istanbul Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5196-4502","authenticated-orcid":false,"given":"Burcin","family":"Karamustafaoglu Balci","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology Goztepe Training and Research Hospital Istanbul Medeniyet University  Istanbul Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gokhan","family":"Goynumer","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology D\u00fczce University Faculty of Medicine  D\u00fczce Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,1,23]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dew293"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/0010-7824(94)90109-0"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/0010-7824(90)90035-T"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/det050"},{"key":"e_1_2_8_6_1","first-page":"CD005072","article-title":"Levonorgestrel\u2010releasing intrauterine device (LNG\u2010IUD) for symptomatic endometriosis following surgery","volume":"1","author":"Abou\u2010Setta AM","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e31824264c3"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(03)00608-3"},{"key":"e_1_2_8_9_1","first-page":"CD009590","article-title":"Endometriosis: an overview of Cochrane Reviews","volume":"3","author":"Brown J","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpobgyn.2006.01.012"},{"key":"e_1_2_8_11_1","first-page":"1","article-title":"The LNG IUD device and endometriosis staging","volume":"87","author":"Gomes MK","year":"2006","journal-title":"Fertil Steril"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(03)00175-4"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deh004"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deh869"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(99)00291-5"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(00)01759-3"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deh650"}],"container-title":["Australian and New Zealand Journal of Obstetrics and Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fajo.12773","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajo.12773","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T03:07:51Z","timestamp":1694920071000},"score":1,"resource":{"primary":{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/10.1111\/ajo.12773"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,23]]},"references-count":16,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["10.1111\/ajo.12773"],"URL":"https:\/\/doi.org\/10.1111\/ajo.12773","archive":["Portico"],"relation":{},"ISSN":["0004-8666","1479-828X"],"issn-type":[{"value":"0004-8666","type":"print"},{"value":"1479-828X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,23]]},"assertion":[{"value":"2017-06-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-12-17","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-01-23","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}